what effect will glutathione binding have on cancer Frontiers Glutathione responsive nanomedicine leverages tumor
Description
Large biomarker development programs are undertaken to identify disease signatures that will improve patient selection and outcome measures in clinical trials
Available from: 140.Ministry of Health and Family Welfare
doi: 10.1042/bj2170851 68 ChackoBKKramerPARaviSJohnsonMSHardyRWBallingerSWet al
14 min 5% A, 95% B until 15 min
Glutamine indirectly deactivates cPLA2 by dephosphorylating p38 MAPK, the major kinase for cPLA2 phosphorylation, through inducing MAPK phosphatase-1 (MKP-1)
Or these data can be accessed in NCBI SRA database ( by PRJNA743131
